Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Tofacitinib Citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12,852Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Specgx’s Generics Tofacitinib Receives Tentative Approval in US
    Specgx’s Generics Tofacitinib Receives Tentative Approval in US

    06 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219395

    FDA
    06 Mar 2026
    Share Share
    Breckenridge Pharms’ Generics Tofacitinib Receives Approval in US
    Breckenridge Pharms’ Generics Tofacitinib Receives Approval in US

    19 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209633

    FDA
    19 Feb 2026
    Share Share
    Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER
    Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER

    23 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/biocon-pharma-gets-fda-nod-for-arthritis-drug-tofacitinib-er-18314

    INDPHARMAPOST
    23 Nov 2025
    Share Share
    Biocon’s Generics Tofacitinib Receives Tentative Approval in US
    Biocon’s Generics Tofacitinib Receives Tentative Approval in US

    17 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219442

    FDA
    17 Nov 2025
    Share Share
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218407

    FDA
    08 Oct 2025
    Share Share
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence

    24 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241024256878/en

    BUSINESSWIRE
    24 Oct 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.